Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ELISPOT cell rescue.

Duncan A Meiklejohn1, R Karl Karlsson, Annika C Karlsson

  • 1Gladstone Institute of Virology and Immunology, University of California, PO Box 419100, San Francisco, CA 94141-9100, USA.

Journal of Immunological Methods
|June 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural history of NGLY1 deficiency: motor function & clinical features.

Human molecular genetics·2026
Same author

EBV Triggers a Distinct Antiviral Response in HMC3 Cells.

bioRxiv : the preprint server for biology·2026
Same author

Human endogenous retrovirus profiling reveals heterogenous expression in cutaneous melanoma.

Frontiers in oncology·2026
Same author

HIV Nef-mediated WAVE2-ARP2/3 inhibition underlies CD4<sup>+</sup> T-cell lamellipodial abnormalities and immune dysfunction.

mBio·2026
Same author

Surgical Management of Recurrent Tracheal Stenosis in the Setting of Riedel's Thyroiditis.

The Annals of otology, rhinology, and laryngology·2026
Same author

Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound.

Immunity·2026
Same journal

Optimized intracellular flow cytometry panel enables CD4 and CD8 T cell cytokine profiling in Syrian hamsters.

Journal of immunological methods·2026
Same journal

Isosulfan blue sentinel lymph node biopsy enables reliable lymph node harvest and multicolor flow cytometry in mice.

Journal of immunological methods·2026
Same journal

Type-specific antibody detection of herpes simplex virus types 1&2 (HSV-1&2) in fingerstick blood at point-of-care sites by a rapid and sensitive lateral flow immunochromatographic assay.

Journal of immunological methods·2026
Same journal

Development of chimeric DGP-IgG antibodies as quality control for celiac disease diagnosis.

Journal of immunological methods·2026
Same journal

Stepwise single-cell-resolved deep immunophenotyping pipeline to characterise immune heterogeneity and functionality in health and disease.

Journal of immunological methods·2026
Same journal

Performance evaluation of Meso Scale Discovery (MSD) quantitative serological assays for detection of binding (IgG, IgA, IgM) and ACE2 inhibitory antibody levels for SARS-CoV-2.

Journal of immunological methods·2026
See all related articles

Researchers can now rescue viable T cells from enzyme-linked immunospot (ELISPOT) assays for further analysis. This method maximizes data from limited samples in vaccine trials.

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • The enzyme-linked immunospot (ELISPOT) assay is crucial for measuring T cell responses post-vaccination.
  • Field settings for vaccine trials face limitations in blood volume and measurable antigen-specific responses due to cell numbers.

Purpose of the Study:

  • To determine if viable cells can be salvaged from completed ELISPOT assays for subsequent experiments.
  • To enhance sample utility and data yield from T cell assays in vaccine studies.

Main Methods:

  • Cells were rescued from ELISPOT plates after the assay incubation period.
  • The viability of rescued cells was assessed.
  • Rescued cells were utilized in secondary cytokine production assays, proliferation assays, and for DNA extraction.

Main Results:

Related Experiment Videos

  • Cells rescued from ELISPOT assays remain viable.
  • Rescued cells can be successfully used in downstream functional assays (cytokine production, proliferation).
  • DNA can be extracted from rescued cells for genetic analyses like HLA typing.

Conclusions:

  • Salvaging cells post-ELISPOT assay is feasible and maintains cell viability.
  • This technique significantly increases the utility of limited samples in T cell immunology and vaccine research.
  • Rescuing cells enables multiple downstream analyses, maximizing data acquisition from vaccine trials.